Zhitong Financial APP News, Voice Pharmaceutical (02096) announced that on May 11, 2022, it has been decided to grant a total of 6.81 million restricted shares, equivalent to 6.81 million related shares, to a total of 21 selected persons (who are employees of the Group) under the 2021 restricted share Unit Plan, which is yet to be accepted by the grantee.

The announcement states that the grant of a total of 6.81 million restricted share units must be made from the 34000 unvested shares currently held and managed by the Tricor trustee as part of the trust fund under the 2021 restricted share unit scheme; and by the issue and allotment of 6.776 million new shares to the Tricor trustee in accordance with the terms of the General mandate and the 2021 restricted share unit scheme. As at the date of this announcement, 31.49 million shares have been issued and allotted in accordance with the General mandate. Under the 2021 restricted share Unit Scheme, the company is required to pay for new shares with its internal resources, while the trustee of Tricor is required to subscribe for new shares in cash. New shares account for approximately 0.256% of the total number of issued shares expanded by the issuance and allotment of new shares on the date of this announcement.